BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Giaquinta S, Michaels MG, Mccullers JA, Wang L, Fonnesbeck C, O'shea A, Green M, Halasa NB. Randomized, double-blind comparison of standard-dose vs. high-dose trivalent inactivated influenza vaccine in pediatric solid organ transplant patients. Pediatr Transplantation 2015;19:219-28. [DOI: 10.1111/petr.12419] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 5.9] [Reference Citation Analysis]
Number Citing Articles
1 Aslam S, Danziger-Isakov L, Mehra MR. COVID-19 vaccination immune paresis in heart and lung transplantation. J Heart Lung Transplant 2021;40:763-6. [PMID: 34144891 DOI: 10.1016/j.healun.2021.04.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
2 Caldera F, Mercer M, Samson SI, Pitt JM, Hayney MS. Influenza vaccination in immunocompromised populations: Strategies to improve immunogenicity. Vaccine 2021;39 Suppl 1:A15-23. [PMID: 33422377 DOI: 10.1016/j.vaccine.2020.11.037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
3 Robertson CA, DiazGranados CA, Decker MD, Chit A, Mercer M, Greenberg DP. Fluzone® High-Dose Influenza Vaccine. Expert Rev Vaccines 2016;15:1495-505. [PMID: 27813430 DOI: 10.1080/14760584.2016.1254044] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 5.5] [Reference Citation Analysis]
4 Paulsen GC, Danziger-Isakov L. Respiratory Viral Infections in Solid Organ and Hematopoietic Stem Cell Transplantation. Clin Chest Med 2017;38:707-26. [PMID: 29128020 DOI: 10.1016/j.ccm.2017.07.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 5.4] [Reference Citation Analysis]
5 Cross JW, Joy M, McGee C, Akinyemi O, Gatenby P, de Lusignan S. Adverse events of interest vary by influenza vaccine type and brand: Sentinel network study of eight seasons (2010-2018). Vaccine 2020;38:3869-80. [PMID: 32299719 DOI: 10.1016/j.vaccine.2020.03.034] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Mameli C, Cocchi I, Fumagalli M, Zuccotti G. Influenza Vaccination: Effectiveness, Indications, and Limits in the Pediatric Population. Front Pediatr 2019;7:317. [PMID: 31417886 DOI: 10.3389/fped.2019.00317] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
7 L'Huillier AG, Kumar D. Immunizations in solid organ and hematopoeitic stem cell transplant patients: A comprehensive review. Hum Vaccin Immunother 2015;11:2852-63. [PMID: 26291740 DOI: 10.1080/21645515.2015.1078043] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
8 Chong PP, Avery RK. A Comprehensive Review of Immunization Practices in Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients. Clinical Therapeutics 2017;39:1581-98. [DOI: 10.1016/j.clinthera.2017.07.005] [Cited by in Crossref: 59] [Cited by in F6Publishing: 44] [Article Influence: 11.8] [Reference Citation Analysis]
9 Ison MG, Hirsch HH. Community-Acquired Respiratory Viruses in Transplant Patients: Diversity, Impact, Unmet Clinical Needs. Clin Microbiol Rev 2019;32:e00042-19. [PMID: 31511250 DOI: 10.1128/CMR.00042-19] [Cited by in Crossref: 41] [Cited by in F6Publishing: 21] [Article Influence: 13.7] [Reference Citation Analysis]
10 Mombelli M, Rettby N, Perreau M, Pascual M, Pantaleo G, Manuel O. Immunogenicity and safety of double versus standard dose of the seasonal influenza vaccine in solid-organ transplant recipients: A randomized controlled trial. Vaccine. 2018;36:6163-6169. [PMID: 30181045 DOI: 10.1016/j.vaccine.2018.08.057] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
11 Hakim H, Allison KJ, Van de Velde LA, Tang L, Sun Y, Flynn PM, McCullers JA. Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infection. Vaccine 2016;34:3141-8. [PMID: 27129426 DOI: 10.1016/j.vaccine.2016.04.053] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 5.0] [Reference Citation Analysis]
12 Stucchi RS, Lopes MH, Kumar D, Manuel O. Vaccine Recommendations for Solid-Organ Transplant Recipients and Donors. Transplantation 2018;102:S72-80. [DOI: 10.1097/tp.0000000000002012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 5] [Article Influence: 4.3] [Reference Citation Analysis]
13 Hirzel C, Kumar D. Influenza vaccine strategies for solid organ transplant recipients. Curr Opin Infect Dis 2018;31:309-15. [PMID: 29771697 DOI: 10.1097/QCO.0000000000000461] [Cited by in Crossref: 16] [Cited by in F6Publishing: 4] [Article Influence: 5.3] [Reference Citation Analysis]
14 Bresee JS, Fry AM, Sambhara S, Cox NJ. Inactivated Influenza Vaccines. Plotkin's Vaccines. Elsevier; 2018. pp. 456-488.e21. [DOI: 10.1016/b978-0-323-35761-6.00031-6] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
15 Lee JKH, Lam GKL, Shin T, Kim J, Krishnan A, Greenberg DP, Chit A. Efficacy and effectiveness of high-dose versus standard-dose influenza vaccination for older adults: a systematic review and meta-analysis. Expert Rev Vaccines 2018;17:435-43. [PMID: 29715054 DOI: 10.1080/14760584.2018.1471989] [Cited by in Crossref: 65] [Cited by in F6Publishing: 63] [Article Influence: 16.3] [Reference Citation Analysis]
16 Cordero E, Roca-Oporto C, Bulnes-Ramos A, Aydillo T, Gavaldà J, Moreno A, Torre-Cisneros J, Montejo JM, Fortun J, Muñoz P, Sabé N, Fariñas MC, Blanes-Julia M, López-Medrano F, Suárez-Benjumea A, Martinez-Atienza J, Rosso-Fernández C, Pérez-Romero P; TRANSGRIPE 1–2 Study Group. Two Doses of Inactivated Influenza Vaccine Improve Immune Response in Solid Organ Transplant Recipients: Results of TRANSGRIPE 1-2, a Randomized Controlled Clinical Trial. Clin Infect Dis 2017;64:829-38. [PMID: 28362949 DOI: 10.1093/cid/ciw855] [Cited by in Crossref: 64] [Cited by in F6Publishing: 52] [Article Influence: 12.8] [Reference Citation Analysis]
17 Bosaeed M, Kumar D. Seasonal influenza vaccine in immunocompromised persons. Hum Vaccin Immunother 2018;14:1311-22. [PMID: 29485353 DOI: 10.1080/21645515.2018.1445446] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
18 Haddadin Z, Krueger K, Thomas LD, Overton ET, Ison M, Halasa N. Alternative strategies of posttransplant influenza vaccination in adult solid organ transplant recipients. Am J Transplant 2021;21:938-49. [PMID: 32885604 DOI: 10.1111/ajt.16295] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 9.5] [Reference Citation Analysis]
19 Domnich A, Manini I, Calabrò GE, Waure C, Montomoli E. Mapping Host-Related Correlates of Influenza Vaccine-Induced Immune Response: An Umbrella Review of the Available Systematic Reviews and Meta-Analyses. Vaccines (Basel) 2019;7:E215. [PMID: 31847273 DOI: 10.3390/vaccines7040215] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
20 Jain SR, Kumar D. Vaccination for the post-kidney transplant population. Curr Opin Nephrol Hypertens 2019;28:581-6. [PMID: 31567282 DOI: 10.1097/MNH.0000000000000546] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Papaz T, Allen U, Blydt-Hansen T, Birk PE, Min S, Hamiwka L, Phan V, Schechter T, Wall DA, Urschel S, Foster BJ, Mital S. Pediatric Outcomes in Transplant: PersOnaliSing Immunosuppression To ImproVe Efficacy (POSITIVE Study): The Collaboration and Design of a National Transplant Precision Medicine Program. Transplant Direct 2018;4:e410. [PMID: 30584591 DOI: 10.1097/TXD.0000000000000842] [Cited by in Crossref: 8] [Article Influence: 2.0] [Reference Citation Analysis]
22 Natori Y, Shiotsuka M, Slomovic J, Hoschler K, Ferreira V, Ashton P, Rotstein C, Lilly L, Schiff J, Singer L, Humar A, Kumar D. A Double-Blind, Randomized Trial of High-Dose vs Standard-Dose Influenza Vaccine in Adult Solid-Organ Transplant Recipients. Clin Infect Dis. 2018;66:1698-1704. [PMID: 29253089 DOI: 10.1093/cid/cix1082] [Cited by in Crossref: 77] [Cited by in F6Publishing: 54] [Article Influence: 25.7] [Reference Citation Analysis]
23 Samson SI, Leventhal PS, Salamand C, Meng Y, Seet BT, Landolfi V, Greenberg D, Hollingsworth R. Immunogenicity of high-dose trivalent inactivated influenza vaccine: a systematic review and meta-analysis. Expert Review of Vaccines 2019;18:295-308. [DOI: 10.1080/14760584.2019.1575734] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
24 Mulley WR, Dendle C, Ling JEH, Knight SR. Does vaccination in solid-organ transplant recipients result in adverse immunologic sequelae? A systematic review and meta-analysis. J Heart Lung Transplant. 2018;37:844-852. [PMID: 29609844 DOI: 10.1016/j.healun.2018.03.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 9.0] [Reference Citation Analysis]
25 Donato-Santana C, Theodoropoulos NM. Immunization of Solid Organ Transplant Candidates and Recipients: A 2018 Update. Infect Dis Clin North Am 2018;32:517-33. [PMID: 30146021 DOI: 10.1016/j.idc.2018.04.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
26 Colmegna I, Useche ML, Rodriguez K, Mccormack D, Alfonso G, Patel A, Ramanakumar AV, Rahme E, Bernatsky S, Hudson M, Ward BJ. Immunogenicity and safety of high-dose versus standard-dose inactivated influenza vaccine in rheumatoid arthritis patients: a randomised, double-blind, active-comparator trial. The Lancet Rheumatology 2020;2:e14-23. [DOI: 10.1016/s2665-9913(19)30094-3] [Cited by in Crossref: 9] [Article Influence: 4.5] [Reference Citation Analysis]
27 Ginda T, Taradaj K, Kociszewska-najman B. The influence of selected factors on the immunogenicity of preventive vaccinations against hepatitis A, B and influenza in solid organ transplant recipients undergoing immunosuppressive therapy – a review. Expert Review of Vaccines. [DOI: 10.1080/14760584.2022.2027241] [Reference Citation Analysis]
28 de St Maurice A, Halasa N. Preparing for the 2019-2020 influenza season. Pediatr Transplant 2020;24:e13645. [PMID: 31885157 DOI: 10.1111/petr.13645] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Chang LJ, Anderson EJ, Jeanfreau R, He Y, Hicks B, Shrestha A, Pandey A, Landolfi V, DeBruijn I; QHD04 Study Group. Safety and immunogenicity of high doses of quadrivalent influenza vaccine in children 6 months through <18 years of age: A randomized controlled phase II dose-finding trial. Vaccine 2021;39:1572-82. [PMID: 33610374 DOI: 10.1016/j.vaccine.2021.02.014] [Reference Citation Analysis]
30 Chong PP, Handler L, Weber DJ. A Systematic Review of Safety and Immunogenicity of Influenza Vaccination Strategies in Solid Organ Transplant Recipients. Clinical Infectious Diseases 2018;66:1802-11. [DOI: 10.1093/cid/cix1081] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
31 Hod T, Ben-David A, Olmer L, Scott N, Ghinea R, Mor E, Levy I, Indenbaum V, Lustig Y, Grossman E, Rahav G. BNT162b2 Third Booster Dose Significantly Increases the Humoral Response Assessed by Both RBD IgG and Neutralizing Antibodies in Renal Transplant Recipients. Transpl Int 2022;35:10239. [PMID: 35387393 DOI: 10.3389/ti.2022.10239] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Lai JJ, Lin C, Ho CL, Chen PH, Lee CH. Alternative-Dose versus Standard-Dose Trivalent Influenza Vaccines for Immunocompromised Patients: A Meta-Analysis of Randomised Control Trials. J Clin Med 2019;8:E590. [PMID: 31035712 DOI: 10.3390/jcm8050590] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 de St Maurice A, Halasa N. Immunization and treatment updates: 2016-2017 influenza season. Pediatr Transplant 2017;21. [PMID: 28127885 DOI: 10.1111/petr.12884] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
34 Gattis S, Yildirim I, Shane AL, Serluco S, Mccracken C, Liverman R. Impact of Pharmacy-Initiated Interventions on Influenza Vaccination Rates in Pediatric Solid Organ Transplant Recipients. Journal of the Pediatric Infectious Diseases Society 2019;8:525-30. [DOI: 10.1093/jpids/piy095] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
35 Danziger‐isakov L, Kumar D; The AST ID Community of Practice. Vaccination of solid organ transplant candidates and recipients: Guidelines from the American society of transplantation infectious diseases community of practice. Clin Transplant 2019;33. [DOI: 10.1111/ctr.13563] [Cited by in Crossref: 133] [Cited by in F6Publishing: 103] [Article Influence: 44.3] [Reference Citation Analysis]
36 Cordero E, Bulnes-Ramos A, Aguilar-Guisado M, González Escribano F, Olivas I, Torre-Cisneros J, Gavaldá J, Aydillo T, Moreno A, Montejo M, Fariñas MC, Carratalá J, Muñoz P, Blanes M, Fortún J, Suárez-Benjumea A, López-Medrano F, Roca C, Lara R, Pérez-Romero P. Effect of Influenza Vaccination Inducing Antibody Mediated Rejection in Solid Organ Transplant Recipients. Front Immunol 2020;11:1917. [PMID: 33123119 DOI: 10.3389/fimmu.2020.01917] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
37 Mombelli M, Kampouri E, Manuel O. Influenza in solid organ transplant recipients: epidemiology, management, and outcomes. Expert Review of Anti-infective Therapy 2020;18:103-12. [DOI: 10.1080/14787210.2020.1713098] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
38 Law N, Kumar D. Post-transplant Viral Respiratory Infections in the Older Patient: Epidemiology, Diagnosis, and Management. Drugs Aging 2017;34:743-54. [PMID: 28965331 DOI: 10.1007/s40266-017-0491-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
39 Marinelli TM, Kumar D. Influenza Virus Infection and Transplantation. Transplantation 2021;105:968-78. [PMID: 33044429 DOI: 10.1097/TP.0000000000003486] [Reference Citation Analysis]
40 Dulek DE, de St Maurice A, Halasa NB. Vaccines in pediatric transplant recipients-Past, present, and future. Pediatr Transplant 2018;22:e13282. [PMID: 30207024 DOI: 10.1111/petr.13282] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
41 Halasa NB, Savani BN, Asokan I, Kassim A, Simons R, Summers C, Bourgeois J, Clifton C, Vaughan LA, Lucid C, Wang L, Fonnesbeck C, Jagasia M. Randomized Double-Blind Study of the Safety and Immunogenicity of Standard-Dose Trivalent Inactivated Influenza Vaccine versus High-Dose Trivalent Inactivated Influenza Vaccine in Adult Hematopoietic Stem Cell Transplantation Patients. Biology of Blood and Marrow Transplantation 2016;22:528-35. [DOI: 10.1016/j.bbmt.2015.12.003] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 7.2] [Reference Citation Analysis]